Ontology highlight
ABSTRACT: Background
Autonomic nervous dysfunction is a shared clinical feature in Alzheimer's disease (AD) and heart failure (HF). Cholinesterase inhibitors (ChEIs) are widely used autonomic modulators in patients with AD, but their primary preventive benefit on new-onset HF is still uncertain.Objective
This study examined whether ChEIs have a primary preventive effect on new-onset HF in patients with AD.Methods
This propensity score matching (PSM) study was conducted using data from the National Health Insurance Research Database of Taiwan for 1995 to 2017. Certificated patients with AD and without a history of HF were divided into ChEI (donepezil, rivastigmine, or galantamine) users or nonusers. The primary endpoint was new-onset HF, and the secondary endpoints were myocar
SUBMITTER: Hsieh MJ
PROVIDER: S-EPMC8966646 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature